Crypto Cloud Mining - 5% off! -- I'm making $50 per day on AUTO PILOT with Monero Cloud Mining on Genesis-Mining. Cloud mining works! Take 5% off your order with this link. 5% off Coupon code: 08FzhX

Palatin Technologies, Inc.
(NYSE Amex Equities : PTN)

( )
PTN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-2.67%102.021.1%$712.68m
GILDGilead Sciences, Inc.
1.86%81.740.9%$628.55m
AMGNAmgen Inc.
1.33%188.011.1%$462.41m
BIIBBiogen Inc.
1.78%344.871.2%$364.27m
REGNRegeneron Pharmaceuticals, Inc.
1.04%374.072.7%$256.44m
ALXNAlexion Pharmaceuticals, Inc.
-1.90%122.121.9%$226.76m
ILMNIllumina, Inc.
0.26%242.053.5%$220.89m
VRTXVertex Pharmaceuticals Incorporated
0.82%156.991.9%$208.13m
JUNOJuno Therapeutics, Inc.
51.86%69.2513.5%$205.21m
NKTRNektar Therapeutics
-0.49%69.406.1%$163.03m
INCYIncyte Corporation
-1.46%90.312.5%$147.55m
EXASExact Sciences Corporation
-9.95%47.6826.0%$146.25m
BLUEBluebird Bio, Inc.
7.29%175.2516.1%$134.83m
SRPTSarepta Therapeutics, Inc.
1.70%61.1716.8%$113.27m
AAgilent Technologies, Inc.
1.15%72.051.5%$107.90m

Company Profile

Palatin Technologies, Inc. is a biopharmaceutical company which develops targeted, receptor-specific peptide therapeutics for the treatment of diseases. It specializes in molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. It offers product in clinical development is bremelanotide for the treatment of premenopausal women with hypoactive sexual desire disorder, which is a type of female sexual dysfunction, defined as low desire with associated distress. It also offers drug candidates and development programs for cardiovascular diseases and inflammatory diseases. The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Cranbury, NJ.